Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12151525 [patent_doc_number] => 20180022789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-25 [patent_title] => 'GELATIN PARTICLES, METHOD FOR PRODUCING GELATIN PARTICLES, GELATIN-PARTICLECONTAINING CELLS, METHOD FOR PRODUCING GELATIN-PARTICLE-CONTAINING CELLS, AND CELLULAR STRUCTURE' [patent_app_type] => utility [patent_app_number] => 15/650142 [patent_app_country] => US [patent_app_date] => 2017-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9126 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15650142 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/650142
GELATIN PARTICLES, METHOD FOR PRODUCING GELATIN PARTICLES, GELATIN-PARTICLECONTAINING CELLS, METHOD FOR PRODUCING GELATIN-PARTICLE-CONTAINING CELLS, AND CELLULAR STRUCTURE Jul 13, 2017 Abandoned
Array ( [id] => 12449184 [patent_doc_number] => 09982248 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-29 [patent_title] => Factor IX polypeptide mutant, its uses and method for its production [patent_app_type] => utility [patent_app_number] => 15/650070 [patent_app_country] => US [patent_app_date] => 2017-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11894 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15650070 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/650070
Factor IX polypeptide mutant, its uses and method for its production Jul 13, 2017 Issued
Array ( [id] => 12125091 [patent_doc_number] => 20180008677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'MODIFIED VASOACTIVE INTESTINAL PEPTIDES' [patent_app_type] => utility [patent_app_number] => 15/621320 [patent_app_country] => US [patent_app_date] => 2017-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13706 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15621320 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/621320
MODIFIED VASOACTIVE INTESTINAL PEPTIDES Jun 12, 2017 Abandoned
Array ( [id] => 14775067 [patent_doc_number] => 20190262431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-29 [patent_title] => CBL-FAMILY INHIBITOR COMPRISING A CBL-FAMILY TKB DOMAIN BINDING PEPTIDE FOR THE PREVENTION OR TREATMENT OF DISEASES [patent_app_type] => utility [patent_app_number] => 16/307735 [patent_app_country] => US [patent_app_date] => 2017-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21274 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307735 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/307735
CBL-FAMILY INHIBITOR COMPRISING A CBL-FAMILY TKB DOMAIN BINDING PEPTIDE FOR THE PREVENTION OR TREATMENT OF DISEASES Jun 8, 2017 Abandoned
Array ( [id] => 14309619 [patent_doc_number] => 20190144513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-16 [patent_title] => THE CORE DOMAIN OF ANNEXINS AND USES THEREOF IN ANTIGEN DELIVERY AND VACCINATION [patent_app_type] => utility [patent_app_number] => 16/308702 [patent_app_country] => US [patent_app_date] => 2017-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10600 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308702 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/308702
Core domain of annexins and uses thereof in antigen delivery and vaccination Jun 7, 2017 Issued
Array ( [id] => 12660385 [patent_doc_number] => 20180111961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-26 [patent_title] => Purification method for divalent cation binding proteins by anion exchange chromatography [patent_app_type] => utility [patent_app_number] => 15/615696 [patent_app_country] => US [patent_app_date] => 2017-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7286 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15615696 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/615696
Protein purification by anion exchange chromatography Jun 5, 2017 Issued
Array ( [id] => 12119101 [patent_doc_number] => 20180002687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-04 [patent_title] => 'Methods for Enhancing Bacterial Cell Display of Proteins and Peptides' [patent_app_type] => utility [patent_app_number] => 15/613877 [patent_app_country] => US [patent_app_date] => 2017-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20060 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15613877 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/613877
Methods for enhancing bacterial cell display of proteins and peptides Jun 4, 2017 Issued
Array ( [id] => 13343441 [patent_doc_number] => 20180223260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-09 [patent_title] => FUNCTIONALIZED NANOPARTICLES FOR THE INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES AND METHODS FOR THEIR MANUFACTURE AND USE [patent_app_type] => utility [patent_app_number] => 15/613197 [patent_app_country] => US [patent_app_date] => 2017-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15613197 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/613197
FUNCTIONALIZED NANOPARTICLES FOR THE INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES AND METHODS FOR THEIR MANUFACTURE AND USE Jun 2, 2017 Abandoned
Array ( [id] => 12975844 [patent_doc_number] => 20170340698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-30 [patent_title] => CYCLIC PEPTIDE SPECIFICALLY BINDING TO APOPTOTIC CELLS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/612094 [patent_app_country] => US [patent_app_date] => 2017-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11550 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15612094 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/612094
CYCLIC PEPTIDE SPECIFICALLY BINDING TO APOPTOTIC CELLS AND USE THEREOF Jun 1, 2017 Abandoned
Array ( [id] => 16755355 [patent_doc_number] => 10973883 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-13 [patent_title] => Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia [patent_app_type] => utility [patent_app_number] => 16/302324 [patent_app_country] => US [patent_app_date] => 2017-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 12586 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302324 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/302324
Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia May 18, 2017 Issued
Array ( [id] => 15850943 [patent_doc_number] => 10640737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-05 [patent_title] => Cleaning composition [patent_app_type] => utility [patent_app_number] => 15/591676 [patent_app_country] => US [patent_app_date] => 2017-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7283 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15591676 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/591676
Cleaning composition May 9, 2017 Issued
Array ( [id] => 13944681 [patent_doc_number] => 10208096 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-19 [patent_title] => Function suppression type of genetically-modified rhodocytin mutant [patent_app_type] => utility [patent_app_number] => 15/590268 [patent_app_country] => US [patent_app_date] => 2017-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 52 [patent_no_of_words] => 11928 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15590268 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/590268
Function suppression type of genetically-modified rhodocytin mutant May 8, 2017 Issued
Array ( [id] => 14243903 [patent_doc_number] => 10272134 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-30 [patent_title] => Autologous HIV-1 proteins for the treatment of latent HIV-1 infection [patent_app_type] => utility [patent_app_number] => 15/589283 [patent_app_country] => US [patent_app_date] => 2017-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15668 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15589283 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/589283
Autologous HIV-1 proteins for the treatment of latent HIV-1 infection May 7, 2017 Issued
Array ( [id] => 13127495 [patent_doc_number] => 10081668 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-25 [patent_title] => Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection [patent_app_type] => utility [patent_app_number] => 15/497822 [patent_app_country] => US [patent_app_date] => 2017-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 15 [patent_no_of_words] => 18867 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 458 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15497822 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/497822
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection Apr 25, 2017 Issued
Array ( [id] => 14868015 [patent_doc_number] => 20190284249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-19 [patent_title] => BETA-CATENIN BARCODED PEPTIDES [patent_app_type] => utility [patent_app_number] => 16/095879 [patent_app_country] => US [patent_app_date] => 2017-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6957 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095879 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/095879
BETA-CATENIN BARCODED PEPTIDES Apr 23, 2017 Abandoned
Array ( [id] => 12117301 [patent_doc_number] => 20180000887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-04 [patent_title] => 'Treatment of Ascites' [patent_app_type] => utility [patent_app_number] => 15/491613 [patent_app_country] => US [patent_app_date] => 2017-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3139 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15491613 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/491613
Treatment of Ascites Apr 18, 2017 Abandoned
Array ( [id] => 11851675 [patent_doc_number] => 20170226167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'MODIFIED PEPTIDES AND THEIR USE FOR TREATING AUTOIMMUNE DISEASES' [patent_app_type] => utility [patent_app_number] => 15/490378 [patent_app_country] => US [patent_app_date] => 2017-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10818 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15490378 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/490378
MODIFIED PEPTIDES AND THEIR USE FOR TREATING AUTOIMMUNE DISEASES Apr 17, 2017 Abandoned
Array ( [id] => 16878005 [patent_doc_number] => 11028138 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-08 [patent_title] => Compositions and methods for using actin-based peptides to modulate cellular bioactivity and cellular susceptibility to intracellular pathogens [patent_app_type] => utility [patent_app_number] => 15/446240 [patent_app_country] => US [patent_app_date] => 2017-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14785 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15446240 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/446240
Compositions and methods for using actin-based peptides to modulate cellular bioactivity and cellular susceptibility to intracellular pathogens Feb 28, 2017 Issued
Array ( [id] => 18412129 [patent_doc_number] => 11666656 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-06 [patent_title] => Polymeric conjugates and uses thereof [patent_app_type] => utility [patent_app_number] => 16/079123 [patent_app_country] => US [patent_app_date] => 2017-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 32 [patent_no_of_words] => 27515 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079123 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/079123
Polymeric conjugates and uses thereof Feb 23, 2017 Issued
Array ( [id] => 13926173 [patent_doc_number] => 20190046602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-14 [patent_title] => METHODS OF TREATING ACUTE MYELOID LEUKEMIA [patent_app_type] => utility [patent_app_number] => 16/078696 [patent_app_country] => US [patent_app_date] => 2017-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9338 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16078696 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/078696
Methods of treating acute myeloid leukemia Feb 22, 2017 Issued
Menu